43 reports

  • PROBIOTICS SEGMENT TO DOMINATE THE FUNCTIONAL FOOD INGREDIENTS MARKET
  • 6.1 INTRODUCTION

PREBIOTICS RESIST GASTRIC ACIDITY AND HYDROLYSIS CAUSED BY ENZYMES AND GASTROINTESTINAL ABSORPTION.

  • Cholesterol
  • Mineral Supplement
  • Market Size
  • Arla Foods
  • Cargill Inc.

One of the major reasons for the high bioavailability of organic minerals is that, unlike inorganic minerals, these do not interact with fiber, tannin, phytate, silicates, oxalate, or other minerals in the gastrointestinal tract.

  • Mineral Supplement
  • Pig
  • World
  • Alltech Inc.
  • Kemin Industries, Inc.

THE MICROPEARLS SPRAY FREEZING TECHNOLOGY ALLOWS FOR THE TIMELY RELEASE OF THESE ## KEY NUTRIENTS THROUGHOUT AN ANIMAL' S GASTROINTESTINAL TRACT.

  • Mineral Supplement
  • North America
  • United States
  • World
  • Market Size
  • VITAMIN & MINERAL PREMIXES MARKET, BY FUNCTIONALITY

Q. ##.

  • Cholesterol
  • Mineral Supplement
  • Market Size
  • Glanbia plc
  • Nutreco N.V.

MARKET ##.

  • Cholesterol
  • Mineral Supplement
  • APAC
  • World
  • Demand

You can easily book an appointment with one online.

  • Mineral Supplement
  • World
  • Market Size
  • Alltech Inc.
  • Kemin Industries, Inc.

Bile acid sequestrates lead to side effects related to the gastrointestinal tract.

  • Cardiovascular Disease
  • Cholesterol
  • Lipid Modifying Drug
  • Mineral Supplement
  • AstraZeneca PLC

Dietary fibers can act by changing the nature of the contents of the gastrointestinal tract and by changing how other nutrients and chemicals are absorbed.

  • Mineral Supplement
  • China
  • Demand
  • Amway Corporation
  • Joincare Pharmaceutical Group Industry Co., Ltd.
  • WELCHOL SWOT ANALYSIS, 2015

PLOS ONE; ##(##): ##-##.

  • Cholesterol
  • AstraZeneca PLC
  • Cerenis
  • Merck & Co., Inc.
  • The Medicines Company

Dietary fibers can act by changing the nature of the contents of the gastrointestinal tract and by changing how other nutrients and chemicals are absorbed.

  • Energy
  • Mineral Supplement
  • Vitamin
  • China
  • Demand

It is estimated that worldwide one in five men and one in three women are at risk of an osteoporotic fracture.

  • Mineral Supplement
  • World
  • Forecast
  • Quidel Corporation
  • Roche Group

The subsidiary is focused on aging care, critical care & surgery, gastrointestinal function, and pediatrics.

  • Cholesterol
  • Mineral Supplement
  • North America
  • United States
  • Demand

Q. ##.

  • Mineral Supplement
  • United States
  • Cargill Inc.
  • Koninklijke DSM N.V.
  • Nutreco N.V.
  • WELCHOL (COLESEVELAM HCL) SWOT ANALYSIS, 2014

GASTROINTESTINAL SIDE EFFECTS WERE THE MOST COMMON AND INCLUDED ERUCTATION, DIARRHEA, AND NAUSEA.

  • Cholesterol
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • WELCHOL (COLESEVELAM HCL) SWOT ANALYSIS, 2014

GASTROINTESTINAL SIDE EFFECTS WERE THE MOST COMMON AND INCLUDED ERUCTATION, DIARRHEA, AND NAUSEA.

  • Cholesterol
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • WELCHOL (COLESEVELAM HCL) SWOT ANALYSIS, 2014

GASTROINTESTINAL SIDE EFFECTS WERE THE MOST COMMON AND INCLUDED ERUCTATION, DIARRHEA, AND NAUSEA.

  • Cholesterol
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • WELCHOL (COLESEVELAM HCL) SWOT ANALYSIS, 2014

GASTROINTESTINAL SIDE EFFECTS WERE THE MOST COMMON AND INCLUDED ERUCTATION, DIARRHEA, AND NAUSEA.

  • Cholesterol
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

S##. and Rehabilitation; ##(##): ##-##.

  • Cholesterol
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • SMALL MOLECULE TO ANTAGONIZE GABAA RECEPTOR FOR METABOLIC, GASTROINTESTINAL AND CARDIOVASCULAR DISORDERS - DRUG PROFILE
  • DYSLIPIDEMIA - PIPELINE BY SJT MOLECULAR RESEARCH SL, H1 2018

Dyslipidemia - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Dyslipidemia - Pipeline Review, H1 2018, provides an overview of the Dyslipidemia (Metabolic Disorders) pipeline landscape. Dyslipidemia is defined as elevation...

  • Cardiovascular Disease
  • Cholesterol
  • Mineral Supplement
  • Pharmaceutical
  • Amarin Corporation plc
  • Aug 11, 2017: Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • Nov 07, 2017: Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Third Quarter 2017 Financial Results

Inhibition of Niemann-Pick C##-Like ## (NPC##L##) by ezetimibe results in reduced absorption of cholesterol from the gastrointestinal tract, thereby reducing delivery of cholesterol to the liver, which in turn upregulates LDL receptors.

  • Cholesterol
  • Therapy
  • United States
  • Deals & Alliance
  • Esperion Therapeutics, Inc.

There were ## serious adverse events in the study, both unrelated to treatment, one in a placebo and one in a drug-treated patient.

  • Cholesterol
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Synta Pharmaceuticals Corp.

There were ## serious adverse events in the study, both unrelated to treatment, one in a placebo and one in a drug-treated patient.

  • Cholesterol
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Synta Pharmaceuticals Corp.
  • SMALL MOLECULE TO ANTAGONIZE GABAA RECEPTOR FOR METABOLIC, GASTROINTESTINAL AND CARDIOVASCULAR DISORDERS - DRUG PROFILE
  • DYSLIPIDEMIA - PIPELINE BY SJT MOLECULAR RESEARCH SL, H2 2018

Dyslipidemia - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Dyslipidemia - Pipeline Review, H2 2018, provides an overview of the Dyslipidemia (Metabolic Disorders) pipeline landscape. Dyslipidemia is defined as elevation...

  • Cardiovascular Disease
  • Cholesterol
  • Mineral Supplement
  • Pharmaceutical
  • Amarin Corporation plc

The majority of AEs were gastrointestinal.

  • Cholesterol
  • Therapy
  • United States
  • Company
  • Gemphire Therapeutics Inc.

The prominent features of this report are - ##.

  • Cholesterol
  • Mineral Supplement
  • Therapy
  • World
  • Product Initiative
  • HS-25 - Drug Profile

It is found on the gastrointestinal tract epithelial cells as well as in hepatocytes.

  • Cholesterol
  • Mineral Supplement
  • United States
  • Product Initiative
  • Merck & Co., Inc.
  • Phase II - Trial Details
  • R&D Progress Research and Development Brief

It is found on the gastrointestinal tract epithelial cells as well as in hepatocytes.

  • Cholesterol
  • Lipid Modifying Drug
  • Mineral Supplement
  • United States
  • Product Initiative

The company' s products are used in the treatment of cancer, depression, dementia, dermatology, diabetes, anti-inflammatory, cardiovascular, epilepsy, hepatitis, hypnotics, osteoarthritis, gastrointestinal, osteoporosis and others.

  • Cholesterol
  • Mineral Supplement
  • Turkey
  • World
  • Product Initiative

SYMPTOMS INCLUDE GASTROINTESTINAL PAIN, DIFFICULTY BREATHING, MEMORY LOSS, DEMENTIA, XANTHELASMAS AND CORNEAL ARCUS.

  • Cholesterol
  • Mineral Supplement
  • Therapy
  • United States
  • Product Initiative
  • Clinical Trial profile. 479 Trial Title
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Cholesterol
  • Endocrine Disease
  • Mineral Supplement
  • Pharmaceutical
  • World